Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Michael Ruberson Ribeiro da Silva"'
Autor:
Alciellen Mendes da Silva, Ana Luísa Horsth, Élida da Silva Timóteo, Ronaldo José Faria, Patrícia Silva Bazoni, Eduardo Frizzera Meira, Jéssica Barreto Ribeiro dos Santos, Michael Ruberson Ribeiro da Silva
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-9 (2023)
Abstract Medicinal plants are an integrative and complementary health practice widely used by the population. However, its use is not without risks. This study assessed the profile and associated factors with the traditional use of medicinal plants.
Externí odkaz:
https://doaj.org/article/e1665d03c53e403580faf86280bca79d
Autor:
Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro dos Santos, Adriana Maria Kakehasi, Alessandra Maciel Almeida, Pedro Ricardo Kömel Pimenta, Juliana Alvares-Teodoro, Francisco de Assis Acurcio
Publikováno v:
São Paulo Medical Journal (2022)
ABSTRACT BACKGROUND: Psoriatic arthritis (PsA) is a chronic inflammatory disease that affects multiple joints. It is associated with psoriasis and treated with synthetic and biologic drugs. OBJECTIVE: The objective of this study was to assess the out
Externí odkaz:
https://doaj.org/article/9176f8d90f854891873ea8dd69af2e6a
Autor:
Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro dos Santos, Adriana Maria Kakehasi, Alessandra Maciel Almeida, Juliana Alvares-Teodoro Alvares-Teodoro, Francisco de Assis Acurcio
Publikováno v:
Medicina, Vol 55, Iss 2 (2022)
Objective: this study evaluated the biological therapy effects on disease activity, functionality, quality of life, drug survival, and safety of patients with psoriatic arthritis naïve and experienced in biological therapy. Methods: a oneyear prospe
Externí odkaz:
https://doaj.org/article/18b0df3b4421414e8031e69897a100b2
Autor:
Ronaldo José Faria, Francisca Janiclecia Rezende Cordeiro, Jéssica Barreto Ribeiro dos Santos, Juliana Alvares-Teodoro, Augusto Afonso Guerra Júnior, Francisco de Assis Acurcio, Michael Ruberson Ribeiro da Silva
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Conventional synthetic disease-modifying antirheumatic drugs are the first-line treatment to inhibit the progression of psoriatic arthritis. Despite their widespread clinical use, few studies have been conducted to compare these drugs for
Externí odkaz:
https://doaj.org/article/39a1e89d529e4a7fa954c3bc3563a680
Autor:
Elisa Neide Barbosa de Souza, Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro Dos Santos, Edna Afonso Reis, Juliana Alvares-Teodoro, Francisco de Assis Acurcio, Alessandra Maciel Almeida
Publikováno v:
Einstein (São Paulo), Vol 20 (2022)
ABSTRACT Objective To evaluate the therapeutic response (functionality) and its associated factors in patients on biological drugs on the Public Health System for treatment of rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. Meth
Externí odkaz:
https://doaj.org/article/bb489d42792e44d7b2e2f815c4fe886d
Autor:
Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro dos Santos, Alessandra Maciel Almeida, Juliana Alvares-Teodoro, Adriana Maria Kakehasi, Francisco de Assis Acurcio
Publikováno v:
Advances in Rheumatology, Vol 59, Iss 1, Pp 1-9 (2019)
Abstract Background Pharmaceutical Assistance (PA) is a dynamic and multidisciplinary process that aims to supply health systems, programs or services with quality medicines, enabling access and health care, in an efficient and timely manner. The obj
Externí odkaz:
https://doaj.org/article/9f8584fc283b4adaa6a9723fc7c1af52
Publikováno v:
European Journal of Clinical Pharmacology. 78:1749-1761
The involvement of the orexin system in the physiopathology of insomnia has been rapidly increasing in understanding. In this sense, daridorexant was the third orexin receptor antagonist approved by the FDA in January 2022. This review aims to summar
Publikováno v:
Expert Review of Clinical Immunology. 18:879-888
Myasthenia gravis is characterized by fluctuating muscle weakness that improves with rest and worsens with effort or throughout the day.Efgartigimod is a human IgG1-derived Fc fragment modified at five residues to increase its affinity for the neonat
Publikováno v:
Expert Opinion on Drug Delivery. 19:1-7
Standard-of-care treatment for growth hormone deficiency consists of daily subcutaneous injections of recombinant human growth hormone, also known as somatropin. Although somatropin treatment is well established, the burden of daily injections can le
Autor:
Francisco de Assis Acurcio, Adriana Maria Kakehasi, Juliana Alvares-Teodoro, Michael Ruberson Ribeiro da Silva, Jéssica Barreto Ribeiro dos Santos, Pedro Ricardo Kömel Pimenta
Publikováno v:
Journal of Comparative Effectiveness Research. 10:509-517
Aim: To evaluate the effectiveness and safety of anti-TNF drugs for ankylosing spondylitis. Materials & methods: A prospective cohort study was performed at a pharmacy in the Brazilian Public Health System. Effectiveness by Bath Ankylosing Spondyliti